168 related articles for article (PubMed ID: 9375969)
1. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.
Yip J; Chahl LA
Neuroscience; 1999; 94(2):663-73. PubMed ID: 10579226
[TBL] [Abstract][Full Text] [Related]
4. C-FOS expression in the rat brain in response to substance P and neurokinin B.
Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
[TBL] [Abstract][Full Text] [Related]
5. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.
Marco N; Thirion A; Mons G; Bougault I; Le Fur G; Soubrié P; Steinberg R
Neuropeptides; 1998 Oct; 32(5):481-8. PubMed ID: 9845011
[TBL] [Abstract][Full Text] [Related]
6. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):512-9. PubMed ID: 8751080
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation.
Jung M; Michaud JC; Steinberg R; Barnouin MC; Hayar A; Mons G; Souilhac J; Emonds-Alt X; Soubrié P; Le Fur G
Neuroscience; 1996 Sep; 74(2):403-14. PubMed ID: 8865192
[TBL] [Abstract][Full Text] [Related]
8. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
9. Localization of tachykinin receptors and Fos-like immunoreactivity induced by substance P in guinea-pig brain.
Yip J; Chahl LA
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):943-6. PubMed ID: 11071315
[TBL] [Abstract][Full Text] [Related]
10. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
[TBL] [Abstract][Full Text] [Related]
11. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
Sandoval-Guzmán T; Rance NE
Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
[TBL] [Abstract][Full Text] [Related]
12. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide.
Smith ME; Flynn FW
J Comp Neurol; 2000 Oct; 426(3):413-28. PubMed ID: 10992247
[TBL] [Abstract][Full Text] [Related]
14. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Emonds-Alt X; Proietto V; Steinberg R; Advenier C; Daoui S; Naline E; Gueudet C; Michaud JC; Oury-Donat F; Poncelet M; Vilain P; Le Fur G; Maffrand JP; Soubrié P; Pascal M
Can J Physiol Pharmacol; 2002 May; 80(5):482-8. PubMed ID: 12056557
[TBL] [Abstract][Full Text] [Related]
17. Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig.
Linari G; Broccardo M; Nucerito V; Improta G
Peptides; 2002 May; 23(5):947-53. PubMed ID: 12084527
[TBL] [Abstract][Full Text] [Related]
18. Roles of neuronal NK1 and NK3 receptors in synaptic transmission during motility reflexes in the guinea-pig ileum.
Johnson PJ; Bornstein JC; Burcher E
Br J Pharmacol; 1998 Aug; 124(7):1375-84. PubMed ID: 9723948
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
20. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
Corboz MR; Rivelli MA; Eckel SP
Exp Lung Res; 2010 Nov; 36(9):509-21. PubMed ID: 20939761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
